Article Versions Notes

Cataldo A, Romero-Cordoba S, Plantamura I, Cosentino G, Hidalgo-Miranda A, Tagliabue E, Iorio MV. MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer. Cancers. 2020; 12(8):2261. https://doi.org/10.3390/cancers12082261

Cataldo, Alessandra, Sandra Romero-Cordoba, Ilaria Plantamura, Giulia Cosentino, Alfredo Hidalgo-Miranda, Elda Tagliabue, and Marilena V. Iorio. 2020. "MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer" Cancers 12, no. 8: 2261. https://doi.org/10.3390/cancers12082261

Cataldo, A., Romero-Cordoba, S., Plantamura, I., Cosentino, G., Hidalgo-Miranda, A., Tagliabue, E., & Iorio, M. V. (2020). MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer. Cancers, 12(8), 2261. https://doi.org/10.3390/cancers12082261